TABLE OF CONTENTS
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market - By Applications
1.3.2 Global Nuclear Medicine/Radiopharmaceuticals Market - By End User
1.3.3 Global Nuclear Medicine/Radiopharmaceuticals Market - By Geography
2. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 COVERAGE
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
4. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
5. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET - KEY INDUSTRY DYNAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Rising Prevalence of Chronic Diseases
5.1.2 Alpha Radioimmunotherapy-Based Targeted Oncology Treatment
5.1.3 Advancement in Imaging Technologies using Radiopharmaceuticals
5.2 KEY MARKET RESTRAINTS
5.2.1 Short Shelf-Life of Radiopharmaceuticals
5.2.2 Availability of Substitutes of Radiopharmaceuticals
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Development in the Healthcare Market
5.3.2 High Market Potential in Emerging Nations
5.4 CURRENT TREND
5.4.1 Use of Nuclear Medicine For Personalized Treatment
5.5 IMPACT ANALYSIS
6. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET - GLOBAL ANALYSIS
6.1 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE FORECASTS AND ANALYSIS
6.2 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
6.3 PERFORMANCE/ POSITIONING OF KEY PLAYERS
6.3.1 Cardinal Health
6.3.2 GENERAL ELECTRIC
7. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET ANALYSIS- BY APPLICATIONS
7.1 OVERVIEW
7.2 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET BY APPLICATIONS, 2018 & 2027 (%)
7.3 DIAGNOSTIC APPLICATIONS MARKET
7.3.1 Overview
7.3.2 Global Diagnostic Applications Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 SPECT (Single-Photon Emission Computed Tomography) Applications Market
7.3.3.1 Overview
7.3.3.2 Global SPECT (Single-Photon Emission Computed Tomography) Applications Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 PET (Positron Emission Tomography) Applications Market
7.3.4.1 Overview
7.3.4.2 Global PET (Positron Emission Tomography) Applications Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 THERAPEUTIC APPLICATIONS MARKET
7.4.1 Overview
7.4.2 Global Therapeutic Applications Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Thyroid Market
7.4.3.1 Overview
7.4.3.2 Global Thyroid Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Bone Metastasis Market
7.4.4.1 Overview
7.4.4.2 Global Bone Metastasis Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.5 Lymphoma Market
7.4.5.1 Overview
7.4.5.2 Global Lymphoma Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.6 Endocrine Tumors Market
7.4.6.1 Overview
7.4.6.2 Global Endocrine Tumors Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.7 Other Therapeutic Applications Market
7.4.7.1 Overview
7.4.7.2 Global Other Therapeutic Applications Market Revenue and Forecasts to 2027 (US$ Mn)
8. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET ANALYSIS- BY END USER
8.1 OVERVIEW
8.2 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY END USER 2018 & 2027 (%)
8.3 HOSPITALS MARKET
8.3.1 Overview
8.3.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 DIAGNOSTIC CENTERS MARKET
8.4.1 Overview
8.4.2 Global Diagnostic Centers Market Revenue and Forecasts to 2025 (US$ Mn)
9. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1 NORTH AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027
9.1.1 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.1.2.1 North America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.2.2 North America Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.3 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.4 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)
9.1.5 US Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6 US Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 US Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.1.6.1.1 US Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.1.2 US Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.2 US Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.1.7.2.1 Canada Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.2.2 Canada Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7.4 Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.5 Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.6 Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.1.7.6.1 Mexico Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.6.2 Mexico Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.7 Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2 EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027
9.2.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.2.2.1 Europe Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.2.2 Europe Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.4 Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)
9.2.5 UK Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.5.1 UK Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.5.2 UK Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.2.5.2.1 UK Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.5.2.2 UK Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.5.3 UK Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.6 Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.2 Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.2.6.2.1 Germany Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.6.2.2 Germany Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.6.3 Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.7 France Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 France Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.2 France Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.2.7.2.1 France Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.7.2.2 France Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.7.3 France Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.8 Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.2 Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.2.8.2.1 Italy Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.8.2.2 Italy Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.8.3 Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.9 Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.2 Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.2.9.2.1 Spain Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.9.2.2 Spain Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.9.3 Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3 ASIA PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027
9.3.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.3.2.1 Asia Pacific Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.2.2 Asia Pacific Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.4 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)
9.3.5 Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.5.1 Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.5.2 Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.3.5.2.1 Japan Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.5.2.2 Japan Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.5.3 Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.6 China Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.1 China Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.2 China Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.3.6.2.1 China Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.6.2.2 China Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.6.3 China Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.7 India Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 India Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.2 India Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.3.7.2.1 India Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.7.2.2 India Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.7.3 India Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.7.4 South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.5 South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.6 South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.3.7.6.1 South Korea Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.7.6.2 South Korea Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.7.7 South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.8 Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.1 Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.2 Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.3.8.2.1 Australia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.8.2.2 Australia Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.8.3 Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 MIDDLE EAST & AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027
9.4.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.4.2.1 Middle East & Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.2.2 Middle East & Africa Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5 MIDDLE EAST & AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
9.5.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)
9.5.2 UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.2.1 UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.2.2 UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.5.2.2.1 UAE Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.2.2.2 UAE Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.2.3 UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5.3 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.3.1 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.3.2 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.5.3.2.1 Saudi Arabia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.3.2.2 Saudi Arabia Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.3.3 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5.4 South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.4.1 South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.4.2 South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.5.4.2.1 South Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.4.2.2 South Africa Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.4.3 South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.6 SOUTH AND CENTRAL AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027
9.6.1 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6.2 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.6.2.1 South and Central America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.6.2.2 South and Central America Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.6.3 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.6.4 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)
9.6.5 Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6.5.1 Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6.5.2 Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.6.5.2.1 Argentina Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.6.5.2.2 Argentina Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.6.5.3 Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.6.6 Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6.6.1 Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6.6.2 Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
9.6.6.2.1 Brazil Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.6.6.2.2 Brazil Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.6.6.3 Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET- INDUSTRY LANDSCAPE
10.1 OVERVIEW
10.2 COMPARATIVE COMPANY ANALYSIS
10.3 GROWTH STRATEGIES DONE BY THE COMPANIES IN THE MARKET, (%)
10.4 ORGANIC DEVELOPMENTS
10.4.1 Overview
10.5 INORGANIC DEVELOPMENTS
10.5.1 Overview
11. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET-KEY COMPANY PROFILES
11.1 CARDINAL HEALTH
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Information
11.1.4 Product Portfolio
11.1.5 Swot Analysis
11.1.6 Key Developments
11.2 GENERAL ELECTRIC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 IBA WORLDWIDE
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 CURIUM
11.4.1 Key Facts
11.4.2 Business Description
11.4.1 Financial Information
11.4.2 Product Portfolio
11.4.3 SWOT Analysis
11.4.4 Key Developments
11.5 POSITRON CORPORATION
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 LANTHEUS MEDICAL IMAGING, INC.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 Product Pipeline
11.6.6 SWOT Analysis
11.6.7 Key Developments
11.7 NTP RADIOISOTOPES SOC LTD (NECSA)
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 BAYER AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 Product Pipeline
11.8.6 SWOT Analysis
11.8.7 Key Developments
11.9 BRACCO
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 ADVANCED ACCELERATOR APPLICATIONS (NOVARTIS AG)
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 Product Pipeline
11.10.6 SWOT Analysis
11.10.7 Key Developments
12. APPENDIX
12.1 ABOUT THE INSIGHT PARTNERS
12.2 GLOSSARY OF TERMS
LIST OF TABLES
TABLE 1. PRINCIPAL RADIONUCLIDES USED IN DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS
TABLE 2. NORTH AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 3. NORTH AMERICA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 4. NORTH AMERICA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 5. NORTH AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 6. US NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 7. US DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 8. US THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 9. US NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 10. CANADA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 11. CANADA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 12. CANADA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 13. CANADA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 14. MEXICO NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 15. MEXICO DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 16. MEXICO THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 17. MEXICO NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 18. EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 19. EUROPE DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 20. EUROPE THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 21. EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 22. UK NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 23. UK DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 24. UK THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 25. UK NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 26. GERMANY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 27. GERMANY DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 28. GERMANY THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 29. GERMANY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 30. FRANCE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 31. FRANCE DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 32. FRANCE THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 33. FRANCE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 34. ITALY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 35. ITALY DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 36. ITALY THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 37. ITALY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 38. SPAIN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 39. SPAIN DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 40. SPAIN THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 41. SPAIN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 42. ASIA PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 43. ASIA PACIFIC DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 44. ASIA PACIFIC THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 45. ASIA PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 46. JAPAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 47. JAPAN DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 48. JAPAN THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 49. JAPAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 50. CHINA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 51. CHINA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 52. CHINA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 53. CHINA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 54. INDIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 55. INDIA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 56. INDIA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 57. INDIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 58. SOUTH KOREA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 59. SOUTH KOREA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 60. SOUTH KOREA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 61. SOUTH KOREA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 62. AUSTRALIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 63. AUSTRALIA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 64. AUSTRALIA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 65. AUSTRALIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 66. MIDDLE EAST & AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 67. MIDDLE EAST & AFRICA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 68. MIDDLE EAST & AFRICA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 69. MIDDLE EAST & AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 70. UAE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 71. UAE DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 72. UAE THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 73. UAE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 74. SAUDI ARABIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 75. SAUDI ARABIA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 76. SAUDI ARABIA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 77. SAUDI ARABIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 78. SOUTH AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 79. SOUTH AFRICA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 80. SOUTH AFRICA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 81. SOUTH AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 82. SOUTH AND CENTRAL AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 83. SOUTH AND CENTRAL AMERICA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 84. SOUTH AND CENTRAL AMERICA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 85. SOUTH AND CENTRAL AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 86. ARGENTINA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 87. ARGENTINA DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 88. ARGENTINA THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 89. ARGENTINA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 90. BRAZIL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATIONS (US$ MN)
TABLE 91. BRAZIL DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 92. BRAZIL THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 93. BRAZIL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 94. ORGANIC DEVELOPMENTS DONE BY COMPANIES
TABLE 95. INORGANIC DEVELOPMENTS DONE BY COMPANIES
TABLE 96. GLOSSARY OF TERMS, NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
LIST OF FIGURES
FIGURE 1. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SEGMENTATION
FIGURE 2. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS SEGMENTATION, BY REGION
FIGURE 3. ASIA PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
FIGURE 4. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET BY APPLICATIONS MARKET SHARE (%), 2018
FIGURE 5. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET BY END USER, MARKET SHARE (%), 2018
FIGURE 6. NORTH AMERICA : PEST ANALYSIS
FIGURE 7. EUROPE : PEST ANALYSIS
FIGURE 8. ASIA - PACIFIC : PEST ANALYSIS
FIGURE 9. MIDDLE EAST & AFRICA : PEST ANALYSIS
FIGURE 10. SOUTH & CENTRAL AMERICA : PEST ANALYSIS
FIGURE 11. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
FIGURE 12. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET - REVENUE FORECASTS AND ANALYSIS - 2019- 2027
FIGURE 13. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2019- 2027
FIGURE 14. MARKET POSITIONING OF KEY PLAYER IN GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
FIGURE 15. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY APPLICATIONS 2018 & 2027 (%)
FIGURE 16. GLOBAL DIAGNOSTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. GLOBAL SPECT (SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY) APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. GLOBAL PET (POSITRON EMISSION TOMOGRAPHY) APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. GLOBAL THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 20. GLOBAL THYROID MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. GLOBAL BONE METASTASIS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 22. GLOBAL LYMPHOMA MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. GLOBAL ENDOCRINE TUMORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 24. GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY END USER 2018 & 2027 (%)
FIGURE 26. GLOBAL HOSPITALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 27. GLOBAL DIAGNOSTIC CENTERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 28. NORTH AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 29. NORTH AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 30. NORTH AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 31. US NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 32. CANADA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 33. MEXICO NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 34. EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 35. EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 36. EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 37. UK NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 38. GERMANY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 39. FRANCE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 40. ITALY NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 41. SPAIN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 42. ASIA PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 43. ASIA PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 44. ASIA PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 45. JAPAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 46. CHINA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 47. INDIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 48. SOUTH KOREA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 49. AUSTRALIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 50. MIDDLE EAST & AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 51. MIDDLE EAST & AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 52. MIDDLE EAST & AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 53. UAE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 54. SAUDI ARABIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 55. SOUTH AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 56. SOUTH AND CENTRAL AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 57. SOUTH AND CENTRAL AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 58. SOUTH AND CENTRAL AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 59. ARGENTINA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 60. BRAZIL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 61. COMPARATIVE COMPANY ANALYSIS
FIGURE 62. GROWTH STRATEGIES DONE BY THE COMPANIES IN THE MARKET, (%)